Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score

American Journal of Roentgenology

Volumn 188, Issue 6, 2007, Pages 1521-1528

  Robertson, Patricia L ^a   Maas, Mario ^b   Goldblatt, Jack ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Bone marrow burden score; Enzyme replacement therapy; Gaucher's disease; MRI; Musculoskeletal system

Indexed keywords

ALGLUCERASE;

ADULT; AGED; ARTICLE; BONE MARROW BURDEN SCORING SYSTEM; COHORT ANALYSIS; ENZYME REPLACEMENT; FEMALE; FEMUR; GAUCHER DISEASE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; SCORING SYSTEM; SKELETON; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; BONE MARROW; COHORT STUDIES; FEMALE; FEMUR; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34249882193     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.06.1410     Document Type: Article

References (20)

1. Barton NW, Brady RC, Dambrosia JM, et al. Replacement therapy for inherited enzyme deficiency: macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 1991; 324:1464-1470
2. Goldblatt J, Szer J, Fletcher JM, McGill J, Rowell JA, Wilson M. Enzyme replacement therapy for Gaucher disease in Australia. Intern Med J 2005; 35:156-161
3. Rosenthal DI, Barton NW, McKusick KA, et al. Quantitative imaging of Gaucher disease. Radiology 1992; 185:841-845
4. Magnaldi S, Longo R, Ukmar M, Zanatta M, Bottega M, Sottocasa GL. Bone marrow relaxation times in Gaucher disease before and after enzyme replacement therapy. Eur Radiol 1997; 7:486-491
5. Hollak C, Maas M, Akkerman E, den Heeten A, Aerts H. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease. Blood Cells Mol Dis 2001; 27:1005-1012
6. Maas M, Hollak CE, Akkerman EM, Aerts JM, Stoker J, Den Heeten GJ. Quantification of skeletal involvement in adults with type 1 Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. AJR 2002; 179:961-965
7. Vlieger EJ, Maas M, Akkerman EM, Hollak CE, Den Heeten GJ. Vertebra disc ratio as a parameter for bone marrow involvement and its application in Gaucher disease. J Comput Assist Tomogr 2002; 26:843-848
8. Terk MR, Dardashti S, Liebman HA. Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume. Skeletal Radiol 2000; 29:563-571
9. Hermann G, Pastores GM, Abdelwahab IF, Lorberboym AM. Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement. Skeletal Radiol 1997; 26:687-696
10. Hermann G, Shapiro RS, Abdelwahab IF, Grabowski G. MR imaging in adults with Gaucher disease type I: evaluation of marrow involvement and disease activity. Skeletal Radiol 1993; 22:247-251
11. Terk MR, Esplin J, Lee K, Magre G, Colletti PM. MR imaging of patients with type 1 Gaucher's disease: relationship between bone and visceral changes. AJR 1995; 165:599-604
12. Roca M, Mota J, Giraldo P, Perez Calvo J, Gomez Pereda R, Giralt M. Magnetic resonance in the diagnosis of extent and osseous complications of Gaucher's disease type 1 [in Spanish]. Rev Clin Esp 1997; 197:550-554
13. Poll LW, Koch J-A, vom Dahl S, et al. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results. Skeletal Radiol 2001; 30:496-503
14. Poll LW, Maas M, Terk MR, et al. Response of Gaucher bone disease to enzyme replacement therapy. Br J Radiol 2002; 75[suppl 1]:A25-A36
15. Maas M, van Kuijk C, Stoker J, et al. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging - initial experience. Radiology 2003; 229:554-561
16. Maas M, Poll LW, Terk MR. Imaging and quantifying skeletal involvement in Gaucher disease. Br J Radiol 2002; 75[suppl 1]:A13-A24
17. de Post M, Hollak CE, Groener JE, et al. Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-centre retrospective analysis. Blood 2006; 108:830-835
18. Australian Government Department of Health and Aging Web site. Canberra: Australian Government Department of Health and Aging, 2003. HSGA Medical Genetic Therapy Working Party Guidelines for treatment of Gaucher Disease by enzyme replacement with Imiglucerase. Available at: www.health.gov.au/internet/wcms/ publishing.nsf/ Content/health-pbs-general-supply-othersupply-copy2/ $FILE/gaucherguidelines.pdf. Accessed October 2006
19. Daniel WW. Biostatistics: a foundation for analysis in the health sciences, 7th ed. New York, NY: Wiley, 1999:150-177
20. vom Dahl S, Poll L, Di Rocco M, et al. Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients. Curr Med Res Opin 2006; 22:1045-1064